Tackling obstructive sleep apnea with pharmacotherapeutics: expert guidance
CD Harding, AL Funetes, A Malhotra - Expert Opinion on …, 2024 - Taylor & Francis
Introduction The efficacy of non-pharmacotherapeutic treatment of obstructive sleep apnea,
a highly prevalent condition with serious cardiometabolic and neurocognitive health …
a highly prevalent condition with serious cardiometabolic and neurocognitive health …
[HTML][HTML] A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apnea
S Parthasarathy, D Hyman, J Doherty, R Saad, J Zhang… - Sleep Medicine, 2024 - Elsevier
Abstract Objectives/Background To estimate prevalence and severity of excessive daytime
sleepiness among patients with obstructive sleep apnea (OSA) who were prescribed …
sleepiness among patients with obstructive sleep apnea (OSA) who were prescribed …
Association between a composite measure of sleep health and depressive symptoms in patients with obstructive sleep apnea treated with CPAP therapy: real-world …
R Furihata, D Endo, K Nagaoka, A Hori, T Ito, T Iwami… - Sleep Medicine, 2024 - Elsevier
Objective Sleep health is known to be multidimensional, and there is increasing clinical
interest in composite sleep health scores that capture the number of adverse sleep …
interest in composite sleep health scores that capture the number of adverse sleep …
Excessive daytime sleepiness is associated with relative delta frequency power among patients with mild OSA
T Howarth, M Tashakori, T Karhu, M Rusanen… - Frontiers in …, 2024 - frontiersin.org
Background Excessive daytime sleepiness (EDS) is a cause of low quality of life among
obstructive sleep apnoea (OSA) patients. Current methods of assessing and predicting EDS …
obstructive sleep apnoea (OSA) patients. Current methods of assessing and predicting EDS …
Real-world impact of continuous positive airway pressure on sleepiness in patients with obstructive sleep apnea in a national registry
Objective Excessive daytime sleepiness (EDS) persists in some patients with obstructive
sleep apnea (OSA) despite continuous positive airway pressure (CPAP) treatment. This …
sleep apnea (OSA) despite continuous positive airway pressure (CPAP) treatment. This …
Long-term efficacy and safety of pitolisant for residual sleepiness due to OSA
JL Pépin, V Attali, C Caussé, J Verbraecken, J Hedner… - Chest, 2024 - Elsevier
Background In people with OSA, excessive daytime sleepiness is a prominent symptom and
can persist despite adherence to CPAP, the first-line therapy for OSA. Pitolisant was effective …
can persist despite adherence to CPAP, the first-line therapy for OSA. Pitolisant was effective …
Guidelines for the assessment and management of residual sleepiness in obstructive apnea-hypopnea syndrome. Endorsed by the French Sleep Research and …
L Barateau, S Baillieul, C Andrejak… - … Medicine and Research, 2024 - Elsevier
Excessive daytime sleepiness (EDS) is frequent among patients with obstructive sleep
apnea hypopnea syndrome (OSAHS) and can persist despite the optimal correction of …
apnea hypopnea syndrome (OSAHS) and can persist despite the optimal correction of …
[HTML][HTML] Sleep disorders and traffic accidents: unveiling the hidden risks
CN Hai, LT Duc - The American Journal of Case Reports, 2024 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Numerous countries, Vietnam included,
have persistently high annual rates of traffic accidents. Despite concerted government efforts …
have persistently high annual rates of traffic accidents. Despite concerted government efforts …
The association between residual excessive sleepiness and polysomnography parameters in patients with obstructive sleep apnea using oral appliances
Y Takigawa, A Furuhashi, M Kato, R Yamanaka… - Journal of Oral and …, 2024 - Elsevier
Objective Oral appliances (OA) are effective in reducing apnea-hypopnea index (AHI) in
patients with obstructive sleep apnea (OSA). However, residual excessive sleepiness (RES) …
patients with obstructive sleep apnea (OSA). However, residual excessive sleepiness (RES) …
Pitolisant: A Game Changer for Managing Sleepiness in OSA?
Pitolisant: A Game Changer for Managing Sleepiness in OSA? Pitolisant: A Game Changer for
Managing Sleepiness in OSA? Chest. 2024 Mar;165(3):486-487. doi: 10.1016/j.chest.2023.12.021 …
Managing Sleepiness in OSA? Chest. 2024 Mar;165(3):486-487. doi: 10.1016/j.chest.2023.12.021 …